Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Z Culig, J Hoffmann, M Erdel et al. · British Journal of Cancer · 1999
Abstract only
Pulmonary and Respiratory Medicine
Filters3 filters applied
Status
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Study type
2 papersQuestions on this topic
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial
J S Waters, A Norman, D Cunningham et al. · British Journal of Cancer · 1999 · Randomised trial
Abstract only